用户名:
密 码:
注册
|
忘记密码?
首 页
药品信息
药品检索
全部药品
适应症分类
热门药品
专利信息
专利检索
专利权人导航
专利权人分组导航
分类查询
IPC导航
热门检索
专利分析
概况
申请趋势分析
申请人分析
发明人分析
IPC分析
项目文档
项目
个人项目
文档
个人文档
企业文档
公共文档
标签
互动
特色功能
广州科技订制咨询
特色资讯
医药新闻
帮助中心
关于本软件
药品
文档
专利
新闻
所有专利
选择导航
专利权人导航
专利权人分组导航
分类导航
专利权人导航
Teva Pharmaceutical Industries, Ltd.(92)
TEVA PHARMA [IL](52)
Teva Pharmaceutical Industries Ltd.(33)
TEVA PHARMA(24)
RATIOPHARM GMBH(20)
Chongqing Pharmaceutical Research Institute Co., Ltd.(19)
TEIKOKU PHARMA USA INC [US](7)
FRENKEL ANTON [IL](7)
GENERICS UK LTD(6)
ACTAVIS GROUP PTC EHF(5)
专利信息
Translation Company
查询条件
展开筛选条件
[药品] 包含 'Rasagiline'
清空条件
查询
分析
排序
公开日
公开号
申请日
申请号
中文标题
英文标题
降序
升序
翻到页码
标题
标题2
专利权人
发明人
附图
摘要
摘要2
优先权号
IPC
专利类型
首页
1
2
3
4
5
6
下页
尾页
共
414
条记录, 当前第1/42页。
公开号
公开日
申请号
申请日
1.
US20140088145A1
2014/3/27
专利标题
:Combination of rasagiline and pridopidine for treating neurodegenerative disorders, in particular huntington's disease
专利权人
:
Teva Pharmaceutical Industries, Ltd.
;
This invention provides a method of treating a patient afflicted with a neurodegenerative disorder e.g. Huntington's disease comprising administering to the patient rasagiline as an add-on therapy to or in combination with pridopidine. This invention also provides a package and a pharmaceutical composition comprising rasagiline and pridopidine for treating a patient afflicted with a neurodegenerative disorder. This invention also provides rasagiline for use as an add-on therapy or in combination...
2.
US20140072526A1
2014/3/13
专利标题
:Method for the production of adsorbates of a rasagiline salt having a water-soluble adjuvant
专利权人
:
RATIOPHARM GMBH
;
The present invention relates to an adsorbate of a pharmaceutically compatible rasagiline salt comprising at least one pharmaceutically compatible adjuvant wherein the at least one pharmaceutically compatible adjuvant is a water-soluble organic solvent and the rasagiline salt is present in the adsorbate as an amorphous substance.
3.
US2014072526A1
2014/3/13
US201314016960
2013/9/3
专利标题
:METHOD FOR THE PRODUCTION OF ADSORBATES OF A RASAGILINE SALT HAVING A WATER-SOLUBLE ADJUVANT
专利权人
:
LEHMANN ALEXANDER [DE]
;
MUSKULUS FRANK [DE]
;
SCHULZE-NAHRUP JULIA [DE]
;
RATIOPHARM GMBH [DE]
;
The present invention relates to an adsorbate of a pharmaceutically compatible rasagiline salt comprising at least one pharmaceutically compatible adjuvant, wherein the at least one pharmaceutically compatible adjuvant is a water-soluble, organic solvent and the rasagiline salt is present in the adsorbate as an amorphous substance.
4.
EP2705021A2
2014/3/12
EP20120766333
2012/5/4
专利标题
:RASAGILINE AND ITS PHARMACEUTICALLY ACCEPTABLE SALTS
专利权人
:
CADILA HEALTHCARE LTD [IN]
;
5.
CN102276491B
2014/3/5
专利标题
:A kind of preparation method of intermediate of rasagiline
专利权人
:
6.
KR20140023872A
2014/2/27
KR20137013167
2011/10/25
专利标题
:DEUTERIUM ENRICHED RASAGILINE
专利权人
:
TEVA PHARMA [IL]
;
7.
WO2014028868A1
2014/2/20
WO2013US55404
2013/8/16
专利标题
:PARENTERAL FORMULATION OF RASAGILINE
专利权人
:
TEVA PHARMA [IL]
;
FITZER-ATTAS CHERYL [US]
;
ELIAZ ROM E [IL]
;
BLAUGRUND ERAN [IL]
;
GROSS AVIVA [IL]
;
MAYK ADI [IL]
;
This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
8.
US2014051767A1
2014/2/20
US201313969295
2013/8/16
专利标题
:PARENTERAL FORMULATIONS OF RASAGILINE
专利权人
:
FITZER-ATTAS CHERYL [US]
;
ELIAZ ROM E [IL]
;
BLAUGRUND ERAN [IL]
;
GROSS AVIVA [IL]
;
MAYK ADI [IL]
;
TEVA PHARMA [IL]
;
This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
9.
US20140051767A1
2014/2/20
专利标题
:Parenteral formulations of rasagiline
专利权人
:
Teva Pharmaceutical Industries, Ltd.
;
This application provides a method of preferentially inhibiting monoamine oxidase A (MAOA) in the brain of a subject relative to in the intestine of the subject comprising parenterally administering to the subject a controlled release formulation comprising a therapeutically effective amount of rasagiline or a pharmaceutically acceptable salt thereof.
10.
CN102048717B
2014/2/19
专利标题
:A kind of stable rasagiline composition
专利权人
:
Chongqing Pharmaceutical Research Institute Co., Ltd.
;
首页
1
2
3
4
5
6
下页
尾页
共
414
条记录, 当前第1/42页。
当前查询条件: [药品] 包含 'Rasagiline'
查询范围
在当前结果中查询
!
专利类型
发明
实用新型
外观设计
!
公开号
CN1234
!
申请号
CN1234
!
专利标题
扩展
PHARMA
!
专利权人
扩展
pfizer
发明人
!
申请日
yyyymmdd
!
公开日
yyyymmdd
优先权号
!
摘要
扩展
PHARMA
IPC
A01B
下载范围
下载第
到
条记录。
下载内容
题录信息
专利全文